Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
XENE · NASDAQ · Pharmaceutical Preparations
$37.04−0.52 (−1.38%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Xenon Pharmaceuticals (XENE) · oqro.io/stocks/XENE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office no longer reported XENE for Q3 2026Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Polar Capital Holdings Plc now owns 5.2% of XENE as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 6, 2026
T. Rowe Price Investment Management, Inc. now owns 8.2% of XENE as a passive investorSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 1, 2026
CEO purchased ~$1.12M of XENE shares in the open marketSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 1, 2026
CFO purchased ~$560K of XENE shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC disclosed a reduced position in XENE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in XENE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Polar Capital Holdings Plc disclosed an increased position in XENE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Westfield Capital Management Co LP disclosed an increased position in XENE for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Duquesne Family Office disclosed a new position in XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Avoro Capital Advisors LLC disclosed an increased position in XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deerfield Management Company, L.P. disclosed an increased position in XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed an increased position in XENE for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Driehaus Capital Management LLC disclosed an increased position in XENE for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed an increased position in XENE for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Polar Capital Holdings Plc disclosed a reduced position in XENE for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a reduced position in XENE for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed a reduced position in XENE for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed a reduced position in XENE for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Driehaus Capital Management LLC disclosed a reduced position in XENE for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Polar Capital Holdings Plc disclosed a reduced position in XENE for Q3 2025Fund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deerfield Management Company, L.P. disclosed a new position in XENE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in XENE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Samlyn Capital, LLC no longer reported XENE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed an increased position in XENE for Q2 2025Insider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$91 of XENE shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
Siren, L.L.C. disclosed a reduced position in XENE for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deep Track Capital, LP disclosed an increased position in XENE for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Avoro Capital Advisors LLC disclosed an increased position in XENE for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Baker Bros. Advisors LP disclosed a reduced position in XENE for Q1 2025Fund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP disclosed a new position in XENE for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Driehaus Capital Management LLC disclosed a reduced position in XENE for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in XENE for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Polar Capital Holdings Plc disclosed an increased position in XENE for Q4 2024Insider trade · Traded Jan 24, 2025 · Filed Jan 28, 2025
CEO sold ~$903K of XENE shares in the open marketSourceInsider trade · Traded Jan 23, 2025 · Filed Jan 28, 2025
CEO sold ~$650K of XENE shares in the open marketSourceInsider trade · Traded Jan 27, 2025 · Filed Jan 28, 2025
CEO sold ~$614K of XENE shares in the open marketSourceInsider trade · Traded Jan 27, 2025 · Filed Jan 28, 2025
CEO sold ~$47K of XENE shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 19, 2024
CFO sold ~$474K of XENE shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 19, 2024
CFO sold ~$297K of XENE shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 23, 2024
Director sold ~$117K of XENE shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 23, 2024
Director sold ~$84K of XENE shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Samlyn Capital, LLC disclosed an increased position in XENE for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Driehaus Capital Management LLC disclosed an increased position in XENE for Q3 2024SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Polar Capital Holdings Plc disclosed an increased position in XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP no longer reported XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Driehaus Capital Management LLC disclosed a reduced position in XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed an increased position in XENE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 11, 2026
Westfield Capital Management Co LP disclosed an increased position in XENE for Q1 2026SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Driehaus Capital Management LLC disclosed a reduced position in XENE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a reduced position in XENE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Polar Capital Holdings Plc disclosed an increased position in XENE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Siren, L.L.C. disclosed an increased position in XENE for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Driehaus Capital Management LLC disclosed an increased position in XENE for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Polar Capital Holdings Plc disclosed a reduced position in XENE for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed an increased position in XENE for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed an increased position in XENE for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP no longer reported XENE for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Perceptive Advisors LLC disclosed a reduced position in XENE for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Polar Capital Holdings Plc disclosed a reduced position in XENE for Q3 2024Source